| PERIOD ENDING | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | 29-Jun-08 | | Total Revenue | 609,022 | 772,054 | 687,042 | 741,905 | | Cost of Revenue | 290,699 | 327,911 | 322,246 | 324,399 | | | Gross Profit | 318,323 | 444,143 | 364,796 | 417,506 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 326,820 | 325,692 | 320,929 | 344,609 | | Non Recurring | 16,363 | 19,158 | 160,430 |
-
| | Others | 36,774 | 35,955 | 33,881 | 32,642 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (61,634) | 63,338 | (150,444) | 40,255 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,514 |
-
| (8,470) | 10,263 | | Earnings Before Interest And Taxes | (57,120) | 65,136 | (143,650) | 50,518 | | Interest Expense | 18,257 | 12,283 | 11,560 | 12,202 | | Income Before Tax | (75,377) | 52,853 | (155,210) | 38,316 | | Income Tax Expense | (1,148) | 25,075 | (40,360) | 17,251 | | Minority Interest |
-
| (130) | (54) | (213) | | | | Net Income From Continuing Ops | (74,229) | 27,648 | (114,904) | 20,852 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 8,611 | 289 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (74,229) | 27,648 | (106,293) | 21,141 | | Preferred Stock And Other Adjustments | (239) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($74,468) | $27,648 | ($106,293) | $21,141 |
|
0.45% Nasdaq 
0.20%
Income Statement
